The relationship between 18F FDG-PETCT derived markers of tumour metabolism and systemic inflammation in patients with recurrent disease following surgery for colorectal cancer

McSorley, S. T. , Khor, B. Y., Tsang, K., Colville, D., Han, S., Horgan, P. G. and McMillan, D. C. (2018) The relationship between 18F FDG-PETCT derived markers of tumour metabolism and systemic inflammation in patients with recurrent disease following surgery for colorectal cancer. Colorectal Disease, 20(5), pp. 407-415. (doi:10.1111/codi.13973)

[img]
Preview
Text
152732.pdf - Accepted Version

853kB

Abstract

Aim: 18F FDG-PETCT derived markers of tumour metabolism have been reported to have prognostic significance in a variety of tumours. Host inflammation is also recognised to have prognostic significance. The aim of the present study was to investigate the relationship between these markers and host systemic inflammation in patients undergoing elective surgery for colorectal cancer. Methods: Patients with histologically confirmed colorectal cancer, who underwent elective surgery between 2008 and 2015, who also underwent 18F FDG-PETCT, at a single centre were included (n =103). Neutrophil lymphocyte ratio (NLR) and modified Glasgow Prognostic Score (mGPS) were derived from routine blood tests. The maximum standardised uptake (SUVmax), peak standardised uptake (SUVpeak), metabolic tumour volume (MTV) and total lesion glycolysis (TLG) were measured. Results: There was no association between 18F FDG-PETCT measures of tumour metabolism and systemic inflammation in the 33 patients who underwent preoperative imaging. Of the 70 patients with recurrent disease who underwent 18F FDG-PETCT during follow up, patients with NLR ≥5 had a significantly higher SUVmax (20 vs 7, p=0.002), SUVpeak (14 vs 5, p<0.001), MTV (29g vs 2g, p=0.001) and TLG (338g vs 9g, p<0.001). Similarly, patients with an mGPS of 1-2 at the time of 18F FDG-PETCT had a significantly higher median SUVmax (11 vs 6, p=0.048), SUVpeak (8 vs 4, p=0.046), MTV (13mL vs 2mL, p=0.005) and TLG (146g vs 10g, p=0.004). Conclusions: The present study reports a direct association between 18F FDG-PETCT derived measures of tumour metabolism and systemic inflammation in patients with recurrent colorectal cancer.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Horgan, Professor Paul and McMillan, Professor Donald and McSorley, Dr Stephen and Han, Dr Sai
Authors: McSorley, S. T., Khor, B. Y., Tsang, K., Colville, D., Han, S., Horgan, P. G., and McMillan, D. C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Colorectal Disease
Publisher:Wiley
ISSN:1462-8910
ISSN (Online):1463-1318
Published Online:25 November 2017
Copyright Holders:Copyright © 2017 The Association of Coloproctology of Great Britain and Ireland
First Published:First published in Colorectal Disease 20(5):407-415
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record